Covered recipient · General Payments record
AIDA L QUINTERO NORIEGA
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$3,936.37
- Reported across 65 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $428.51 | 14 |
| Education | $72.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $255.10 | 7 |
| Janssen Biotech, Inc. | $72.00 | 1 |
| Eli Lilly Export S.A. Puerto Rico Branch | $46.70 | 2 |
| Eli Lilly and Company | $41.68 | 1 |
| E.R. Squibb & Sons, L.L.C. | $22.59 | 1 |
| GENZYME CORPORATION | $21.43 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.01 | 1 |
| Amgen Inc. | $20.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.02 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105337998 | CMS |
| ABBVIE INC. | $25.00 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105338002 | CMS |
| ABBVIE INC. | $125.00 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105338006 | CMS |
| ABBVIE INC. | $25.00 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105338010 | CMS |
| ABBVIE INC. | $25.00 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105338014 | CMS |
| ABBVIE INC. | $24.08 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105338018 | CMS |
| ABBVIE INC. | $25.00 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105338022 | CMS |
| Amgen Inc. | $20.00 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111681158 | CMS |
| E.R. Squibb & Sons, L.L.C. | $22.59 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101567852 | CMS |
| Eli Lilly and Company | $41.68 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136012213 | CMS |
| Eli Lilly Export S.A. Puerto Rico Branch | $23.75 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136012469 | CMS |
| Eli Lilly Export S.A. Puerto Rico Branch | $22.95 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136014963 | CMS |
| GENZYME CORPORATION | $21.43 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139631097 | CMS |
| Janssen Biotech, Inc. | $72.00 | 03/12/2024 | Education | Undisputed | 01/23/2026 | 1078614825 | CMS |
| Novartis Pharmaceuticals Corporation | $21.01 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087254555 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.